MAIA Biotechnology terminates ATM equity offering agreement after raising ~$5.68M

MAIA Biotechnology, Inc.

Suspended sales and gave notice to terminate At The Market Offering Agreement with H.C. Wainwright, effective 7 business days after May 14, 2026.
Since March 28, 2025 prospectus supplement for $11.2M, sold 3,116,012 shares for gross proceeds of approx. $5,680,924.
No further sales under the ATM facility; termination will be effective upon expiration of the notice period.

item 1.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.